1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
Small Business Technology Transfer (STTR) Program is a grant from the National Institute of Mental Health (NIMH) that funds small businesses partnering with nonprofit research institutions to commercialize mental health innovations. The STTR mechanism requires collaboration between a small business and a nonprofit research partner, with the principal investigator allowed to be employed at either entity.
This program supports the development and commercialization of technologies that advance the prevention, diagnosis, and treatment of mental health conditions. Eligible applicants must meet U.S. SBIR/STTR eligibility requirements. Phase IIB awards can reach up to ,000,000 per year for up to three years.
Get alerted about grants like this
Save a search for “National Institute of Mental Health (NIMH, part of NIH)” or related topics and get emailed when new opportunities appear.
Search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
SBIR/STTR Program Infographic - National Institute of Mental Health (NIMH) Due to current HHS and NIH restructuring, some content on nimh. nih. gov is not being updated regularly.
Please refer to clinicaltrials. gov and nih. gov for up-to-date information on NIH research.
Opportunities & Announcements Funding Strategy for Grants Grant Writing & Approval Process SBIR/STTR Program Infographic Use this interactive chart that contains helpful information to guide you through the NIH SBIR/STTR application process. Click though the chart for answers to your related questions.
Start the SBIR/STTR Application Process infographic Confirm Your Small Business Meets Eligibility Requirements Confirm Your Small Business Concern Meets Eligibility Requirements View the eligibility requirements by visiting the SBIR/STTR eligibility criteria webpage. Develop an Innovative Research Idea Develop an Innovative Research Idea Have a ground breaking idea that can be commercialized?
HHS can provide funding for your technology idea! The Omnibus SBIR and STTR solicitations allow small businesses to propose technologies focused on health, life-science or medicine to HHS for funding consideration. Be sure to speak with an HHS SBIR/STTR program manager BEFORE submitting an application.
Program managers will discuss the Institute or Center (IC)’s interest in the proposed technology and can offer application-specific advice. Also, check to see if one of the ICs has issued a targeted SBIR/STTR solicitation about your research topic. SBIR Omnibus and STTR Omnibus Solicitations Complete Required Registrations You must complete multiple registrations prior to preparing an application and applying for funding.
All registrations must be completed prior to the application being submitted. It can take 6 weeks or more to complete the registration process.
SAM (System for Award Management) – required to do business with the U.S. government SAM will issue a 12-character unique entity identifier (UEI) used to complete your full SAM registration and which serves as the official organization identifier in other federal systems eRA Commons – required to do business with NIH and some HHS agencies Grants.
gov – required to submit grant applications through the federal-wide grant portal SBA (Small Business Administration) – required to participate in SBIR and STTR federal funding programs How to Apply - Application Guide , use the “SBIR/STTR Instructions” Follow the funding opportunity instructions “Section IV.
Application and Submission Information” contains opportunity-specific guidance not contained in the application guide Related Notices, which are listed in Part 1. Overview information Find guidance, resources for first-time applicants, and all the necessary forms in one convenient location.
Standard deadlines for the HHS SBIR/STTR Omnibus: January 5, April 5, September 5 For additional information please see our FAQs Submit Your SBIR/STTR Grant Application to NIH Electronically Submit Your SBIR/STTR Grant Application to NIH Electronically Error-free applications must be accepted by Grants. gov with a time stamp on or before 5 p. m.
local time of the submitting organization on the due date. NIH’s late policy does not allow corrections after the due date. Once the application is submitted, the signing official (SO) or PI must check for errors or warnings in eRA Commons.
Errors do STOP application processing and must be corrected. Warnings do not stop application processing and are corrected at the discretion of the applicant. Using ASSIST will help the applicant catch errors before submitting.
Once an error-free application is received by NIH from Grants. gov, the eRA system will assemble the grant application image. Applicants have two business days to view the error free assembled application image before the application automatically moves forward for further processing.
The SO can reject application within viewing window and submit a Changed/Corrected application prior to the due date.
Submit, Track, and View Your Application Use eRA Commons to Follow Application Status SBIR/STTR Selection Process and Review Criteria Submission Dates and Review Schedule NIH Center for Scientific Review Evaluates Your Grant NIH Center for Scientific Review Evaluates Your Grant on Scientific and Commercialization Potential NIH uses a rigorous dual peer review system to ensure only the most meritorious scientific proposals are funded.
For SBIR/STTR applications, a technology’s commercialization potential is also evaluated during the review process.
NIH Peer Review Policies and Practices NIH Peer Review Process Overview and Scoring Criteria NIH Center for Scientific Review Small Business Study Sections Funding Decisions and Awards are Made Funding Decisions and Awards are Made Once the applicant has gone through peer review, the Advisory Council/Board of the potential awarding Institute or Center (IC) performs the second level of review and gives advice to the IC staff and IC director.
The IC director makes the final funding decisions based on staff and Advisory Council/Board advice. Applicants must ensure that all of the Just-In-Time reporting requirements have been met, which includes the IRB approval, Federal-wide Assurance (FAW) and Human Subjects Education Training. View the NIH SBIR/STTR Just-in-Time (JIT) Procedures Module for information on how to submit all required documentation.
If the application is funded, the small business will receive a Notice of Award . If the application is not funded, the IC program officer can discuss how the application can be revised so it may be funded in the future.
Post-award Monitoring and Reporting NIH SBIR/STTR Just-in-Time (JIT) Procedures Module Awardee Conducts Research Awardee Conducts Research The awardee will need a great deal of information to be a successful steward of federal funds. The NIH Welcome Wagon Letter provides information and resources for new grantee organizations on how to manage the award.
View the NIH Grants Policy Statement for comprehensive information about the post-award processes and requirements. For specific questions, consult the appropriate NIH program officer or grants management specialist.
Proof of Concept/ Feasibility Study for 6 months to 2 years Technical and Business Assistance (TABA) program for NIH SBIR/STTR Phase I and Phase I Fast-Track awardees provides a report assessing the current state of the Phase I project toward commercialization. The report identifies strengths and weaknesses that can help the company strategize for the project’s next steps.
For more information see the Technical and Business Assistance (TABA) Needs Assessment webpage . The objective of Phase I is to establish the technical merit, feasibility, and commercial potential of the proposed R&D efforts prior to further federal support in Phase II. See Budget and Timelines for Funding for additional information.
One application for Phase I and Phase II that is submitted and reviewed together. The Congressional authority for SBIR Direct Phase II is reinstated until FY2022 . Bypass Phase I if feasibility studies are completed.
Full R&D for 1 to 3 Years For Phase II or IIB Awardees Technical and Business Assistance (TABA) program to help NIH SBIR/STTR Phase II/IIB awardees in one of the following areas: For more information see the TABA Consulting Services webpage . The objective of Phase II is to continue the R&D efforts initiated in Phase I.
Funding is based on the results achieved in Phase I and the scientific and technical merit and commercial potential of the project proposed in Phase II. See Budget and Timelines for Funding for additional information. $1M Per Year for Up to 3 Years - Must Have Initial Phase II to Apply Some NIH ICs offer Phase IIB awards for projects that require extraordinary time and effort in the R&D phase.
These awards normally do not exceed $1,000,000 per year for up to 3 years. Talk to your IC program officer if your small business is interested in a Phase IIB award. Commercialization Readiness Program (CRP) SBIR or STTR-supported projects may benefit from funding and support above and beyond the Phase II or Phase IIB awards.
The CRP Program provides additional technical assistance and late-stage research and development support not typically covered within small business awards to help products get to market. Commercialization - Non-SBIR/STTR Funds The objective of Phase III is for the small business to pursue commercialization objectives resulting from the Phase I/II/IIB R&D activities. The NIH SBIR program does not fund Phase III.
Based on current listing details, eligibility includes: US small businesses meeting SBIR/STTR eligibility criteria; STTR requires partnership with a nonprofit research institution and the PI may be employed by either entity. Applicants should confirm final requirements in the official notice before submission.
Current published award information indicates Up to $1,000,000 per year for up to 3 years (Phase IIB) Always verify allowable costs, matching requirements, and funding caps directly in the sponsor documentation.
The current target date is rolling deadlines or periodic funding windows. Build your timeline backwards from this date to cover registrations, approvals, attachments, and final submission checks.
Federal grant success rates typically range from 10-30%, varying by agency and program. Build a strong proposal with clear objectives, measurable outcomes, and a well-justified budget to improve your chances.
Requirements vary by sponsor, but typically include a project narrative, budget justification, organizational capability statement, and key personnel CVs. Check the official notice for the complete list of required attachments.
Yes — AI tools like Granted can help research funders, draft proposal sections, and check compliance. However, always review and customize AI-generated content to reflect your organization's unique strengths and the specific requirements of the solicitation.
Review timelines vary by funder. Federal agencies typically take 3-6 months from submission to award notification. Foundation grants may be faster, often 1-3 months. Check the program's timeline in the official solicitation for specific dates.
Many federal programs offer multi-year funding or allow competitive renewals. Check the official solicitation for continuation and renewal policies. Non-competing continuation applications are common for multi-year awards.
NCI Continuing Umbrella of Research Experiences (CURE) Academic Career Excellence (ACE) Award (K32) is a grant from the National Cancer Institute (NCI) that funds early postdoctoral fellows from diverse backgrounds, including underrepresented groups, to pursue research training in cancer-related fields. The K32 award supports fellows within 12 months prior to transitioning into, or within the first two years of, a postdoctoral position. The program, operated through NCI's Center to Reduce Cancer Health Disparities (CRCHD), aims to enhance the pool of qualified diverse cancer researchers. Beginning with the June 12, 2025 due date, the CURE ACE Award is available in both Independent Clinical Trial Required and Independent Clinical Trial Not Allowed versions. Eligible applicants must be U.S. citizens or permanent residents at time of award.
AAI Career Awards is a grant from the American Association of Immunologists (AAI) that honors members for outstanding research and career achievement. Through multiple award tracks — including the Lifetime Achievement Award, Distinguished Service Award, Distinguished Fellows program, Public Service Award, and Vanguard Award — AAI recognizes immunologists at every career stage who have made exceptional scientific, institutional, or public-policy contributions. Nominations originate from the AAI Council and designated committees. The program celebrates careers defined by scientific excellence, service to the immunology community, and contributions to public advocacy, minority recruitment in the sciences, and disease research. Deadline is September 10, 2025.